BIOMAT Database Logo BIOMAT Database Logo

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. 1993

J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Rega Institute for Medical Research, K. U. Leuven, Belgium.

Serial passage of HIV-1 in CEM or MT-4 cell cultures in the presence of different HIV-1-specific reverse transcriptase (RT) inhibitors yielded mutant viruses which were resistant (i.e., 200- to 1000-fold less sensitive) to the homologous compounds. The RT of these mutant HIV-1 strains showed different amino acid substitutions depending on the class of the HIV-1-specific RT inhibitors. The following amino acid substitutions were found: 138 Glu-->Lys (TSAO-T), 181 Tyr-->Cys (nevirapine), 181 Tyr-->Cys (pyridinone), and 100 Leu-->Ile (TIBO R82150). Four TIBO (R82913)-resistant HIV-1 strains contained different amino acid substitutions: 103 Lys-->Asn (strain 2), 100 Leu-->Ile and 138 Glu-->Lys (strain B02), 100 Leu-->Ile and 181 Tyr-->Cys (strain 1), 100 Leu-->Ile and 188 Tyr-->His (strain B22). The level of cross-resistance (or sensitivity) highly depends on the nature of the amino acid substitutions. As a rule, the TSAO-resistant HIV-1 strains (138 Glu-->Lys) and TIBO (R82150 or R82913)-resistant HIV-1 strains (Leu 100-->Ile or 103 Lys-->Asn) are sensitive to the other HIV-1-specific RT inhibitors, whereas the amino acid change 181 Tyr-->Cys results in a significant reduction of sensitivity to all classes of the HIV-1-specific RT inhibitors.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012194 RNA-Directed DNA Polymerase An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Polymerase, RNA-Directed,RNA-Dependent DNA Polymerase,Reverse Transcriptase,RNA Transcriptase,Revertase,DNA Polymerase, RNA Directed,DNA Polymerase, RNA-Dependent,RNA Dependent DNA Polymerase,RNA Directed DNA Polymerase
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015751 Genes, pol DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. "pol" is short for polymerase, the enzyme class of reverse transcriptase. pol Genes,pol Gene,Gene, pol

Related Publications

J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Specific HIV-1 reverse transcriptase inhibitors.
January 1992, Journal of enzyme inhibition,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
December 2020, European journal of medicinal chemistry,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase.
July 2006, AIDS (London, England),
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
QSAR studies for diarylpyrimidines against HIV-1 reverse transcriptase wild-type and mutant strains.
February 2009, European journal of medicinal chemistry,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors.
May 2011, Virology journal,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
HIV-1 reverse transcriptase inhibitors.
June 2007, Applied microbiology and biotechnology,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains.
April 2007, Bioorganic & medicinal chemistry letters,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Inhibitors of HIV-1 reverse transcriptase.
January 2008, Advances in pharmacology (San Diego, Calif.),
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Novel HIV-1 reverse transcriptase inhibitors.
June 2008, Virus research,
J Balzarini, and A Karlsson, and M J Pérez-Pérez, and L Vrang, and J Walbers, and H Zhang, and B Oberg, and A M Vandamme, and M J Camarasa, and E De Clercq
Inhibitors of HIV-1 reverse transcriptase.
January 2000, Advances in pharmacology (San Diego, Calif.),
Copied contents to your clipboard!